Enovix Statistics
Total Valuation
Enovix has a market cap or net worth of $870.01 million. The enterprise value is $885.06 million.
| Market Cap | 870.01M |
| Enterprise Value | 885.06M |
Important Dates
The next confirmed earnings date is Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Enovix has 212.72 million shares outstanding. The number of shares has increased by 8.37% in one year.
| Current Share Class | 212.72M |
| Shares Outstanding | 212.72M |
| Shares Change (YoY) | +8.37% |
| Shares Change (QoQ) | +0.49% |
| Owned by Insiders (%) | 11.45% |
| Owned by Institutions (%) | 50.76% |
| Float | 188.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 25.35 |
| Forward PS | 17.90 |
| PB Ratio | 3.61 |
| P/TBV Ratio | 4.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 25.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.97, with a Debt / Equity ratio of 2.24.
| Current Ratio | 10.97 |
| Quick Ratio | 10.47 |
| Debt / Equity | 2.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.64 |
Financial Efficiency
Return on equity (ROE) is -71.31% and return on invested capital (ROIC) is -18.24%.
| Return on Equity (ROE) | -71.31% |
| Return on Assets (ROA) | -16.68% |
| Return on Invested Capital (ROIC) | -18.24% |
| Return on Capital Employed (ROCE) | -22.81% |
| Weighted Average Cost of Capital (WACC) | 12.05% |
| Revenue Per Employee | $51,691 |
| Profits Per Employee | -$258,270 |
| Employee Count | 664 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 2.00 |
Taxes
| Income Tax | -1.28M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.70% in the last 52 weeks. The beta is 2.34, so Enovix's price volatility has been higher than the market average.
| Beta (5Y) | 2.34 |
| 52-Week Price Change | -69.70% |
| 50-Day Moving Average | 6.00 |
| 200-Day Moving Average | 7.03 |
| Relative Strength Index (RSI) | 37.72 |
| Average Volume (20 Days) | 6,334,839 |
Short Selling Information
The latest short interest is 52.55 million, so 24.70% of the outstanding shares have been sold short.
| Short Interest | 52.55M |
| Short Previous Month | 50.76M |
| Short % of Shares Out | 24.70% |
| Short % of Float | 27.90% |
| Short Ratio (days to cover) | 9.64 |
Income Statement
In the last 12 months, Enovix had revenue of $34.32 million and -$171.49 million in losses. Loss per share was -$0.81.
| Revenue | 34.32M |
| Gross Profit | 7.40M |
| Operating Income | -177.89M |
| Pretax Income | -172.61M |
| Net Income | -171.49M |
| EBITDA | -142.56M |
| EBIT | -178.59M |
| Loss Per Share | -$0.81 |
Balance Sheet
The company has $528.74 million in cash and $543.79 million in debt, with a net cash position of -$15.05 million or -$0.07 per share.
| Cash & Cash Equivalents | 528.74M |
| Total Debt | 543.79M |
| Net Cash | -15.05M |
| Net Cash Per Share | -$0.07 |
| Equity (Book Value) | 242.73M |
| Book Value Per Share | 1.13 |
| Working Capital | 507.60M |
Cash Flow
In the last 12 months, operating cash flow was -$111.46 million and capital expenditures -$15.17 million, giving a free cash flow of -$126.63 million.
| Operating Cash Flow | -111.46M |
| Capital Expenditures | -15.17M |
| Depreciation & Amortization | 36.03M |
| Net Borrowing | 359.03M |
| Free Cash Flow | -126.63M |
| FCF Per Share | -$0.60 |
Margins
| Gross Margin | 21.55% |
| Operating Margin | -518.28% |
| Pretax Margin | -502.91% |
| Profit Margin | n/a |
| EBITDA Margin | -415.33% |
| EBIT Margin | -520.32% |
| FCF Margin | n/a |
Dividends & Yields
Enovix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.37% |
| Shareholder Yield | -8.37% |
| Earnings Yield | -19.71% |
| FCF Yield | -14.55% |
Analyst Forecast
The average price target for Enovix is $12.95, which is 216.63% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.95 |
| Price Target Difference | 216.63% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 95.50% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Enovix has an Altman Z-Score of 0.12 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.12 |
| Piotroski F-Score | 4 |